| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Heart, Lung, and Blood Institute (NHLBI) |
| Information provided by: | National Institutes of Health Clinical Center (CC) |
| ClinicalTrials.gov Identifier: | NCT00001872 |
Purpose
Blood contains different kinds of cells, white blood cells, red blood cells, and platelets. In order to treat certain diseases, specific cell types can be removed from blood and transplanted into patients. The process of removing white blood cells for the treatment of leukemia is called apheresis.
This study will make available blood cell collections from volunteers genetically matched to various degrees with recipients in order to test and, if necessary, refine the process of removing white blood cell T-lymphocytes.
| Condition |
|
Graft vs Host Disease Hematologic Neoplasm |
| MedlinePlus related topics: | Bone Marrow Transplantation Cancer |
| Study Type: | Observational |
| Study Design: | Prospective |
| Official Title: | Apheresis of Family Members of Patients Undergoing Allogeneic Bone Marrow Transplantation. A Pre-Clinical Study of Selective Depletion of Donor Lymphocytes to Prevent Acute Graft-Versus-Host Disease |
| Estimated Enrollment: | 40 |
| Study Start Date: | February 1999 |
This protocol has been written to make available apheresis collections from volunteers matched to various degrees with recipients in order to test and, if necessary refine, the selective immunodepletion procedure prior to introducing it in a clinical trial.
Eligibility
| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Family members of patients admitted to NHLBI allogeneic BMT protocols.
Ages 18 and older and less than age 65.
Parent of patient (obligate haplotype match) OR HLA 3/6, 4/6/, 5/6/, or 6/6 match with patient.
Research apheresis available from patient.
EXCLUSION CRITERIA:
Pregnancy or lactation.
HLA type unknown.
More than one haplotype mismatch with patient.
History of any immunosuppressive disease
History of chronic viral antigenic stimulus
Venous access inadequate.
Contacts and Locations| Contact: Patient Recruitment and Public Liaison Office | (800) 411-1222 | prpl@mail.cc.nih.gov |
| Contact: TTY | 1-866-411-1010 |
| United States, Maryland | |||||
| National Institutes of Health Clinical Center, 9000 Rockville Pike | Recruiting | ||||
| Bethesda, Maryland, United States, 20892 | |||||
More Information
NIH Clinical Center Detailed Web Page
|
| Study ID Numbers: | 990037, 99-H-0037 |
| First Received: | November 3, 1999 |
| Last Updated: | November 25, 2008 |
| ClinicalTrials.gov Identifier: | NCT00001872 |
| Health Authority: | United States: Federal Government |
|
|
|
|
